Business Context and Reporting Period
Enovix Corporation filed a Form 8-K on September 13, 2023, reporting its entry into a cash deposit agreement with OCBC Bank (Malaysia) Berhad. The agreement supports manufacturing operations for Enovix products under a long-term manufacturing agreement with YBS International Berhad and its subsidiary, Orifast Solution Sdn Bhd (OSSB).
Financial Obligations and Liquidity
- OCBC offered OSSB a loan of up to $70 million under a July 13, 2023 loan agreement to finance manufacturing operations.
- Enovix will deposit cash into a restricted OCBC account based on OSSB’s loan drawdowns. The deposits collateralize OSSB’s indebtedness to OCBC.
- Enovix did not expect to make any cash deposit during the quarter ending October 1, 2023. Future deposits are to be disclosed in Enovix’s consolidated financial statements.
- The deposit earns interest at a variable rate. Enovix may withdraw earned interest provided sufficient collateral remains to satisfy the indebtedness.
- The filing does not provide revenue, profit, cash flow, margin, debt-balance, or other operating financial metrics for the reporting period.
Material Changes and Key Terms
- Enovix became directly subject to collateral and indemnification obligations in connection with OSSB’s loan.
- While the loan remains outstanding, Enovix generally may not withdraw, pledge, transfer, or otherwise deal with the deposit without OCBC’s consent.
- OCBC may require Enovix to deposit additional amounts, up to the amount of OSSB’s indebtedness, to maintain required collateral coverage.
- Enovix may prepay the OCBC indebtedness without penalty.
- Enovix agreed to indemnify OCBC for specified losses related to unenforceability, defaults, failed recovery, preservation of security, insolvency-related claims, and certain legal proceedings.
- The Deposit Agreement is governed by Malaysian law.
Outlook, Risks, and Unusual Items
Management stated that no deposit was expected during the quarter ending October 1, 2023, but future deposits will depend on OSSB’s loan drawdowns. The principal unusual item is the potential restriction of Enovix cash as collateral for a third-party manufacturing loan. Actual collateral requirements could increase if OSSB draws on the loan or if OCBC requires additional security.
The filing’s forward-looking statements regarding expected deposits and future events are subject to risks and uncertainties described in Enovix’s other SEC filings. The filing does not provide additional operating guidance.
Investor Verification Items
- Verify whether OSSB has drawn any portion of the $70 million facility.
- Verify the amount and timing of any restricted cash deposits recorded by Enovix.
- Review subsequent financial statements for collateral balances, interest income, and related-party or contractual disclosures.
- Assess the impact of restricted cash and indemnification obligations on Enovix’s liquidity.
- Review the Manufacturing Agreement and related filings for production commitments, milestones, and counterparty risks.